Lucas Lopes | Medicina | Best Researcher Award

Published on by Neuroscientists

Mr. Lucas Lopes | Medicina | Best Researcher Award

Mr. Lucas Lopes, Universidade de São Paulo, Faculdade de Medicina de Bauru,  Brazil.

Lucas Casagrande Passoni Lopes has made significant strides in medical research, academic publishing, and global scientific collaboration. His expertise in pediatric medicine, endocrinology, and healthcare disparities has been widely recognized through his editorial leadership, peer-review contributions, and multilingual engagements. His published works address critical healthcare issues, further cementing his influence in the medical community.

Profile

Orcid

🎓 Early Academic Pursuits

Lucas Casagrande Passoni Lopes embarked on his academic journey with an unwavering passion for medicine, enrolling in the prestigious Faculdade de Medicina de Bauru at the Universidade de São Paulo, Brazil. His commitment to excellence and keen interest in pediatric and clinical research set the foundation for his future endeavors. Throughout his academic years, he demonstrated exceptional dedication, immersing himself in scientific studies and medical advancements, laying the groundwork for a promising career in healthcare and medical research.

👩‍🎓 Professional Endeavors

Beyond his medical studies, Lucas took on significant roles in the academic publishing landscape. As the In-Chief Editor of Advances in Modern Paediatrics Journal, he has played a pivotal role in shaping pediatric research dissemination. His editorial contributions extend to renowned medical journals, including Journal of Anaesthesia and Global Open Share Publishing, Clinics of Neurology, Annals of Pediatrics and Neonatal Care, and the European Journal of Cancer. Through his editorial expertise, he has facilitated the publication of groundbreaking research, furthering advancements in multiple medical disciplines.

🔬 Contributions and Research Focus

Lucas has established himself as a prolific researcher, focusing on pediatric medicine, endocrinology, and public health concerns. His notable studies include an in-depth analysis of treatments for dysmenorrhea in adolescents, published in Contemporânea – Revista de Ética e Filosofia Política, and a groundbreaking study on the underreporting of diabetes mellitus as a cause of death over 40 years in Bauru, published in Archives of Endocrinology and Metabolism. His work sheds light on critical gaps in healthcare reporting and patient management, making substantial contributions to medical literature and clinical practice.

🏆 Accolades and Recognition

Lucas’ dedication to medical research has earned him esteemed recognition within the scientific community. As an invited reviewer for numerous high-impact journals, including Current Pediatric Reviews, World Journal of Clinical Cases, International Journal of Clinical and Experimental Medical Sciences, World Journal of Gastroenterology, and Frontiers in Medicine, he has been entrusted with evaluating and shaping contemporary medical research. His expertise is widely acknowledged, with his insights influencing the peer-review process across various fields of medicine.

📚 Impact and Influence

Lucas’ influence extends far beyond his research and editorial roles. His multilingual proficiency in Portuguese, English, French, Italian, Spanish, and German allows him to engage with diverse international scientific communities, fostering cross-border collaborations. His involvement in global medical discourse ensures that cutting-edge research reaches a broader audience, ultimately contributing to the improvement of healthcare systems worldwide. His mentorship and editorial leadership have guided emerging researchers, amplifying the impact of his contributions to medical academia.

🌟 Legacy and Future Contributions

With a strong foundation in medical research and editorial expertise, Lucas continues to shape the future of pediatric and clinical medicine. His ongoing commitment to identifying healthcare disparities, advancing treatment methodologies, and supporting evidence-based medical practices positions him as a key figure in modern medical research. As he forges ahead, his contributions promise to enhance patient care, influence policy reforms, and inspire future generations of medical professionals. His legacy in scientific inquiry and knowledge dissemination will undoubtedly leave a lasting mark on the field of medicine.

 

publication

  • Title: Association between exanthematous diseases and earlier age at Type 1 diabetes diagnosis
    Authors: Lucas C.P. Lopes, Lenita Zajdenverg, Rodrigo L.M. Martins, Gabriel Araujo Medeiros, Marina D. Louro, João V.M. Lanzarin, Carlos A. Negrato
    Year: 2025

 

  • Title: Mortality trends from all causes and diabetes mellitus according to sex between 1998 and 2021
    Authors: Carlos Antonio Negrato, Gabriel Araújo Medeiros, Giordano Bruno Duarte de Souza, Lucas Casagrande Passoni Lopes
    Year: 2024

 

  • Title: Relationship between early age at menarche, older age at menopause and subtypes of breast cancer: a scoping review
    Authors: Lucas Casagrande Passoni Lopes, Gabriel Araújo Medeiros, Igor José Nogueira Gualberto, Thales Baptista Gut, Rafael Vasconcelos Silva Ferrazini, Carlos Antonio Negrato
    Year: 2024

 

  • Title: Association between perinatal and obstetric factors and early age at diagnosis of type 1 diabetes mellitus: a cohort study
    Authors: Carlos A. Negrato, Rodrigo L. de M. Martins, Marina D. Louro, Gabriel A. Medeiros, João V.M. Lanzarin, Lenita Zajdenverg, Lucas C.P. Lopes
    Year: 2024

 

  • Title: Underreporting of diabetes mellitus as the cause of death in Bauru, State of São Paulo, Brazil over 40 years: a documental study
    Authors: Lucas Casagrande Passoni Lopes, Gabriel Araújo Medeiros, Mauro Wieczorek, Marina dos Santos de Carvalho Pinto, Carlos Antonio Negrato
    Year: 2024

 

🎉 Conclusion

As a dedicated researcher, editor, and medical professional, Lucas Passoni continues to push the boundaries of medical knowledge and patient care. His contributions have not only enriched scientific literature but have also fostered meaningful discussions on global healthcare improvements. With his unwavering commitment to excellence, Lucas is poised to leave a lasting legacy in the field of medicine, inspiring future generations of researchers and practitioners alike.

 

 

Kiran Solingapuram Sai | Neuroimaging | Best Researcher Award

Published on by Neuroscientists

Dr. Kiran Solingapuram Sai | Neuroimaging | Best Researcher Award

Dr. Kiran Solingapuram Sai, Wake Forest School of Medicine, United States.

Dr. Kiran K. Solingapuram Sai, PhD, is an Associate Professor with tenure in the Department of Radiology at Wake Forest School of Medicine. He holds a Ph.D. in Organic Chemistry from Northern Illinois University and has extensive research experience in radiopharmaceutical chemistry. His postdoctoral training at Washington University’s Mallinckrodt Institute of Radiology focused on radiotracer development.

Profile

Orcid

 

✨ Early Academic Pursuits

Dr. Kiran K. Solingapuram Sai embarked on his academic journey with a strong foundation in chemistry, earning a Bachelor of Science degree in Chemistry, Biochemistry, and Microbiology from Osmania University, Hyderabad, India, in 2001. His passion for organic chemistry led him to pursue a Master of Science in the same field at Osmania University, where he honed his expertise in chemical synthesis and molecular interactions. Determined to explore the depths of organic chemistry, he pursued his Ph.D. at Northern Illinois University, DeKalb, IL, under the mentorship of Dr. Douglas A. Klumpp. During this period, his research focused on synthetic methodologies and organic reaction mechanisms, paving the way for his future contributions to medicinal and radiopharmaceutical chemistry.

🌐 Professional Endeavors

Dr. Sai’s professional journey commenced with a prestigious postdoctoral research associate position at the Mallinckrodt Institute of Radiology at Washington University in St. Louis, MO, where he worked under the guidance of Dr. Robert H. Mach. During his tenure from 2010 to 2013, he delved into the complexities of radiochemistry, developing novel radiotracers and exploring their applications in medical imaging. This experience laid the groundwork for his career in radiopharmaceutical sciences. In 2014, he joined Wake Forest School of Medicine as a Research Instructor and Chief Radiochemist, marking the beginning of his significant contributions to translational imaging and radiopharmaceutical production.

⚛️ Contributions and Research Focus

At Wake Forest School of Medicine, Dr. Sai played a pivotal role in the Department of Radiology and the Clinical Translational Science Institute (CTSI). He specialized in managing clinical and research-based radiopharmaceutical production at the Wake Forest PET Research Center. As a cyclotron manager and coordinator, he oversaw the synthesis and quality control of radiotracers essential for PET imaging. His expertise extended to the development and implementation of cGMP-approved protocols for C-11 and F-18 radiopharmaceutical production, ensuring the highest standards of safety and efficacy. His research focuses on advancing PET imaging techniques, exploring new radiotracers for diagnostic and therapeutic applications, and improving imaging biomarker development.

🏆 Accolades and Recognition

Dr. Sai’s dedication to radiochemistry and molecular imaging has earned him recognition in the scientific community. His work has been instrumental in developing radiopharmaceuticals for neurological and oncological imaging, contributing significantly to early disease detection and targeted therapy. His contributions have been acknowledged through numerous research grants, collaborative projects, and publications in high-impact scientific journals. His commitment to excellence and innovation has positioned him as a leading figure in the field of radiopharmaceutical sciences.

🔬 Impact and Influence

Beyond his research and technical expertise, Dr. Sai has mentored budding scientists and researchers in the field of radiochemistry and imaging sciences. His guidance has helped shape the next generation of radiopharmaceutical experts, fostering a culture of innovation and scientific curiosity. His role in translational imaging programs has bridged the gap between basic research and clinical applications, directly impacting patient care by improving diagnostic imaging techniques.

💡 Legacy and Future Contributions

Dr. Sai’s work continues to inspire advancements in molecular imaging and radiopharmaceutical development. As an Associate Professor with tenure at Wake Forest School of Medicine, he remains dedicated to pushing the boundaries of radiochemistry, developing cutting-edge imaging agents, and enhancing the precision of diagnostic medicine. His legacy in the field is defined by his unwavering commitment to scientific discovery, translational research, and the continuous pursuit of excellence in radiopharmaceutical sciences.Dr. Kiran K. Solingapuram Sai’s contributions to the field of radiopharmaceutical chemistry stand as a testament to his dedication, innovation, and impact on medical imaging and healthcare. His journey from a passionate chemistry student to a distinguished professor and researcher highlights the transformative power of science in shaping the future of medicine.

 

Publication

  1. Radiation-induced brain injury in non-human primates: A dual tracer PET study with [11C]MPC-6827 and [11C]PiB

    • Authors: Naresh Damuka, George W. Schaaf, Mack Miller, Caleb Bradley, Bhuvanachandra Bhoopal, Ivan Krizan, Krishna K. Gollapelli, Christopher T. Whitlow, J. Mark Cline, Kiran K. Solingapuram Sai
    • Year: 2025

 

  1. The β-Secretase 1 Enzyme as a Novel Therapeutic Target for Prostate Cancer

    • Authors: Hilal A. Rather, Sameh Almousa, Ashish Kumar, Mitu Sharma, Isabel Pennington, Susy Kim, Yixin Su, Yangen He, Abdollah R. Ghara, Kiran Kumar Solingapuram Sai et al.
    • Year: 2023

 

  1. Development and Optimization of 11C-Labeled Radiotracers: A Review of the Modern Quality Control Design Process

    • Authors: Paul Josef Myburgh, Kiran Kumar Solingapuram Sai
    • Year: 2023

 

  1. Binding Parameters of [11C]MPC-6827, a Microtubule-Imaging PET Radiopharmaceutical in Rodents

    • Authors: Avinash H. Bansode, Bhuvanachandra Bhoopal, Krishna Kumar Gollapelli, Naresh Damuka, Ivan Krizan, Mack Miller, Suzanne Craft, Akiva Mintz, Kiran Kumar Solingapuram Sai
    • Year: 2023

 

  1. PET Imaging of [11C]MPC-6827, a Microtubule-Based Radiotracer in Non-Human Primate Brains

    • Authors: Naresh Damuka, Paul W. Czoty, Ashley T. Davis, Michael Nader, Susan H. Nader, Suzanne Craft, Shannon L. Macauley, Lindsey K. Galbo Thomma, Phillip M. Epperly, Christopher T. Whitlow et al.
    • Year: 2020

 

  1. One-pot synthesis of novel tert-butyl-4-substituted phenyl-1H-1,2,3-triazolo piperazine/piperidine carboxylates, potential GPR119 agonists

    • Authors: Nagaraju Bashetti, J.V. Shanmukha Kumar, Naresh Varma Seelam, B. Prasanna, Akiva Mintz, Naresh Damuka, Sriram Devanathan, Kiran Kumar Solingapuram Sai
    • Year: 2019

 

Conclusion

Dr. Kiran K. Solingapuram Sai has established himself as a leading expert in radiopharmaceutical sciences, contributing significantly to translational imaging research. His work in PET radiopharmaceutical production and quality assurance underscores his role in advancing medical imaging techniques. His academic and research contributions make him a valuable asset in the field of radiology and molecular imaging.